Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STS | P08842 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 3/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | F2R | P25116 | 1/20 | 0.35 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.35 |
| ▸ | CETP | P11597 | 2/20 | 0.34 |
| ▸ | GRM5 | P41594 | 1/20 | 0.34 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.33 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17986570 | 1.00 | STS (0.36) | STSSIGMAR1SMN1; SMN2TP53POLB | |
| SCHEMBL17986571 | 1.00 | STS (0.36) | STSSIGMAR1SMN1; SMN2TP53POLB | |
| SCHEMBL21268162 | 0.91 | STS (0.36) | STSSMN1; SMN2TP53POLBF2R | |
| SCHEMBL16619599 | 0.91 | STS (0.36) | STSSMN1; SMN2TP53POLBF2R | |
| SCHEMBL21268160 | 0.91 | STS (0.36) | STSSMN1; SMN2TP53POLBF2R | |
| SCHEMBL17986554 | 0.91 | STS (0.36) | STSSMN1; SMN2TP53POLBF2R | |
| SCHEMBL16619243 | 0.90 | ADRB3 (0.40) | STSHSD17B2CETP | |
| SCHEMBL16619242 | 0.90 | ADRB3 (0.40) | STSHSD17B2CETP | |
| SCHEMBL16619692 | 0.87 | TP53 (0.43) | SMN1; SMN2TP53POLBLMNA | |
| SCHEMBL17986588 | 0.87 | TP53 (0.43) | SMN1; SMN2TP53POLBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3052099-A1 | NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS | Merck Sharp & Dohme Corp. (US) | 2016-08-10 | — | — | EP | disclosed |
| WO-2015050798-A1 | NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS | MERCK SHARP & DOHME CORP. (US) | 2015-04-09 | — | — | WO | disclosed |